Rytary

Product manufactured by Impax Specialty Pharma

Application Nr Approved Date Route Status External Links
NDA203312 2015-01-07 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Rytary Is Indicated For The Treatment Of Parkinson's Disease, Post-Encephalitic Parkinsonism, And Parkinsonism That May Follow Carbon Monoxide Intoxication Or Manganese Intoxication. Rytary Is A Combination Of Carbidopa (an Aromatic Amino Acid Decarboxylation Inhibitor) And Levodopa (an Aromatic Amino Acid) Indicated For The Treatment Of Parkinson's Disease, Post-Encephalitic Parkinsonism, And Parkinsonism That May Follow Carbon Monoxide Intoxication Or Manganese Intoxication (1)

All Formulated Excipients (9 Total)

Name Structure Kind Function Status
1. Mannitol MANNITOL Molecular NUTR-Nutrient GRAS-Generally recognized as safe.
2. Tartaric Acid TARTARIC ACID Molecular MISC-Miscellaneous GRAS-Generally recognized as safe.
3. Ethylcelluloses ETHYLCELLULOSES Unresolved
4. Hypromelloses HYPROMELLOSES Unresolved
5. Sodium Lauryl Sulfate SODIUM LAURYL SULFATE Molecular AF-Antifoaming (or defoaming) agent , CTG-Component or coating , EMUL-Emulsifier , SANI-Sanitizing agent , SDA-Solubilizing & dispersing agent REG-Food additives for which a petition has been filed and a regulation issued.
6. Povidones POVIDONES Unresolved
7. Talc TALC Unresolved DYE-Dye GRAS-Generally recognized as safe.
8. Triethyl Citrate TRIETHYL CITRATE Molecular MISC-Miscellaneous GRAS-Generally recognized as safe.
9. Croscarmellose Sodium CROSCARMELLOSE SODIUM Unresolved

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Carbidopa CARBIDOPA ZINC19168887
2. Levodopa LEVODOPA ZINC895199

Comments